Form 8-K - Current report:
SEC Accession No. 0001013762-25-002413
Filing Date
2025-03-26
Accepted
2025-03-26 06:57:20
Documents
15
Period of Report
2025-03-25
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0235617-8k_rafael.htm   iXBRL 8-K 43311
2 PRESS RELEASE, DATED MARCH 26, 2025 ea023561701ex99-1_rafael.htm EX-99.1 11449
3 GRAPHIC ex99-1_001.jpg GRAPHIC 8546
  Complete submission text file 0001013762-25-002413.txt   248103

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE rfl-20250325.xsd EX-101.SCH 3029
5 XBRL LABEL FILE rfl-20250325_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE rfl-20250325_pre.xml EX-101.PRE 22369
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0235617-8k_rafael_htm.xml XML 3556
Mailing Address 520 BROAD STREET NEWARK NJ 07120
Business Address 520 BROAD STREET NEWARK NJ 07120 212-658-1450
Rafael Holdings, Inc. (Filer) CIK: 0001713863 (see all company filings)

EIN.: 822296593 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-38411 | Film No.: 25770081
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)